Lazzini, Gianmarco
Gaeta, Raffele
Pollina, Luca Emanuele
Comandatore, Annalisa
Furbetta, Niccolò
Morelli, Luca
D’Acunto, Mario
Funding for this research was provided by:
Regione Toscana, Italy (ECS_00000017)
Article History
Received: 28 November 2024
Accepted: 9 April 2025
First Online: 17 April 2025
Declarations
:
: The authors declare no competing interests.
: Owing to the observational nature of this study, ethical approval was obtained from CEAVNO (Comitato Etico Regionale per la Sperimentazione Clinica della Toscana - sezione AREA VASTA NORD OVEST) Committee on date 16 February 2023, Protocol Code: PANOMIC; Clinic Study: “Personalized medicine of pancreatic cancer using genomics and avatars”. This study was conducted in accordance with the principles of the Declaration of Helsinki. All patients provided informed consent authorizing the anonymous scientific use of their collected data.